A detailed history of Cibc World Markets Corp transactions in Glaukos Corp stock. As of the latest transaction made, Cibc World Markets Corp holds 4,579 shares of GKOS stock, worth $686,895. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,579
Holding current value
$686,895
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 10, 2025

BUY
$126.42 - $152.67 $578,877 - $699,075
4,579 New
4,579 $686,000
Q1 2024

May 13, 2024

BUY
$76.4 - $96.33 $1.53 Million - $1.93 Million
20,000 New
20,000 $1.89 Million

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $7.14B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Cibc World Markets Corp Portfolio

Follow Cibc World Markets Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc World Markets Corp, based on Form 13F filings with the SEC.

News

Stay updated on Cibc World Markets Corp with notifications on news.